Cash & equivalents decreased 28.3%
Cash & equivalents changed -28.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -28.3% from the comparable as-filed period.
Net income changed -36.6% from the comparable as-filed period.
Operating income changed -34.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating margin changed -620 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +42.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed +22.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +60.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Debt changed +1.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.